1. Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza;Abbott, T. R.Dhamdhere, G.Liu, Y.Lin, X.Goudy, L.Zeng, L.Chemparathy, A.Chmura, S.Heaton, N. S.Debs, R.Pande, T.Endy, D.La Russa, M. F.Lewis, D. B.Qi, L. S.;Cell,2020
2. Recombinant organisms for production of industrial products;Adrio, J. L.Demain, A. L.;Bioengineered Bugs,2010
3. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production;Ahmad, M.Hirz, M.Pichler, H.Schwab, H.,2014
4. Ten years of gene therapy for primary immune deficiencies. Hematology. American Society of Hematology;Aiuti, A.Roncarolo, M. G.,2009
5. Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement;Aiuti, A.Vai, S.Mortellaro, A.Casorati, G.Ficara, F.Andolfi, G.Ferrari, G.Tabucchi, A.Carlucci, F.Ochs, H. D.Notarangelo, L. D.Roncarolo, M. G.Bordignon, C.;Nature Medicine,2002